Navigation Links
Boehringer Ingelheim and Lilly's new oral type 2 diabetes treatment for adults, Jentadueto™ (linagliptin/metformin hydrochloride) tablets, now available in U.S. pharmacies
Date:3/7/2012

Boehringer Ingelheim has been focused on improving the lives of patients. In keeping with the company commitment to do the most good for the most people, Boehringer Ingelheim works hard to ensure its medicines are accessible to patients, including senior citizens and families on limited incomes. The Boehringer Ingelheim Cares Foundation Patient Assistance Programs (BI-PAP) make Boehringer Ingelheim medicines available free of charge to patients who are without pharmaceutical insurance coverage and who meet certain household income levels and eligibility requirements.

To receive an application or inquire about the BI-PAP, please call 1-800-556-8317. Please note, while people of all ages are eligible for the program, applications can be sent only to people at least 18 years of age.

About Diabetes
Approximately 25.8 million Americans(1) and an estimated 366 million people worldwide(2) have type 1 and type 2 diabetes. Type 2 diabetes is the most common type, accounting for an estimated 90 to 95 percent of all diabetes cases.(1) Diabetes is a chronic disease that occurs when the body either does not properly produce, or use, the hormone insulin.(3)

What is JENTADUETO?
JENTADUETO is a prescription medicine that is used along with diet and exercise to lower blood sugar in adults with type 2 diabetes when treatment with both linagliptin and metformin is appropriate.

JENTADUETO is not for people with type 1 diabetes or for people with diabetic ketoacidosis (increased ketones in the blood or urine).

It is not known if JENTADUETO is safe and effective when used with insulin.

IMPORTANT SAFETY INFORMATION

What is the most important information I should know about JENTADUETO?

WARNING: RISK OF LACTIC ACIDOSIS

 

Serious side effects can happen in people taking JENTADUETO. Metformin, one of the medicines in JENT
'/>"/>


SOURCE Eli Lilly and Company
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine technology :

1. Boehringer Ingelheim Initiates NEwArT Study Comparing Viramune(R) (nevirapine) to a Ritonavir-Boosted Atazanavir-based Regimen in Treatment-Naive HIV Patients
2. Boehringer Ingelheim Announces Enrollment is Complete for the Largest Atrial Fibrillation Outcomes Trial - The RE-LY(TM) Study
3. Boehringer Ingelheim to Present New Phase II Clinical Data on Two Lead Oncology Compounds at ASCO 2009
4. Boehringer Ingelheim Unveils Diabetes Pipeline
5. Boehringer Ingelheim Animal Health Closes Deal to Acquire a Significant Portion of the Fort Dodge Animal Health Business From Pfizer
6. Reportlinker Adds Boehringer Ingelheim GmbH: PharmaVitae Profile
7. New Boehringer Ingelheim Science Quest Mobile Laboratory Brings Hands-On Science Education to Priority Connecticut Elementary Schools
8. Boehringer Ingelheim Affirms Safety of Telmisartan With an Analysis of 50,000 Patients and Strongly Disagrees With the Publication of Sipahi et al in Lancet Oncology June 2010
9. -- Neurocrine Announces a Second Corporate Collaboration Within Twenty-Four Hours -- Neurocrine Biosciences Announces a Worldwide Collaboration With Boehringer Ingelheim to Research and Develop GPR119 Agonists for Type II Diabetes
10. Boehringer Ingelheim Announces Pivotal Phase III Data Showing Linagliptin Reduced Blood Sugar Compared to Placebo in People With Type 2 Diabetes
11. Boehringer Ingelheim and MacroGenics Announce Global Alliance to Discover, Develop and Commercialize DART™-Based Antibody Therapeutics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... N.Y. , May 17, 2013  Lakeland Industries, ... manufacturer of protective clothing for industry, healthcare and to ... will release its financial results for the fiscal 2013 ... Tuesday, May 21, 2013 at stock market close and ... at 4:30 p.m. eastern. (Logo: http://photos.prnewswire.com/prnh/20120611/NY21959LOGO ...
(Date:5/17/2013)... 17, 2013  Technology advances have had a ... with a constantly evolving communication environment, companies need ... communicating with internal executives. It is challenging, however, ... tactics and tools that are part of today,s ... study, Best Practices, LLC explores the various internal ...
(Date:5/17/2013)... 17, 2013  Sony Biotechnology Inc. ("Sony") today announced ... (SP6800).  Sony will be exhibiting and taking orders for ... at the San Diego Convention ... from May 20 - 22.  The ... commercial audio-visual technologies into new and novel functionalities for ...
Breaking Medicine Technology:Lakeland Industries to Report Fiscal Fourth Quarter and Year End Financial Results and Conduct Conference Call 2Internal Communication Strategies and Tactics that Resonate with Key Stakeholders and Drive Organizational Effectiveness 2Sony Biotechnology Inc.'s New Technology for Science Provides Researchers Results in Color 2
... Oct. 26, 2011 Perrigo Company (Nasdaq: PRGO;TASE) ... a quarterly dividend of $0.08 per share, payable ... on November 25, 2011. Perrigo Company ... manufactures and distributes OTC and generic prescription (Rx) ...
... PARSIPPANY, N.J., Oct. 26, 2011 Pharmaceutical gurus know that ... industry is to get together with the field,s leading experts. ... overwhelmingly popular event that takes place just once a year: ... February 7-8 at the Hilton Parsippany Hotel in Parsippany, New ...
Cached Medicine Technology:Pharmaceutical Industry Leaders to Tackle Groundbreaking Challenges, Opportunities for Pharma & Biotech at Elite Event 2
(Date:5/19/2013)... The Pradaxa lawyers at Bernstein Liebhard ... convened for hundreds of Pradaxa bleeding lawsuits ... U.S. District Court, Southern District of Illinois. According ... 14th, the Conference addressed the status of depositions and ... Conference that Defendants submitted a list of early trial ...
(Date:5/19/2013)... 2013 Dr. Keith Chertok now provides gum ... unhealthy gums and increase the chance of a healthier smile. ... Attachment Procedure (LANAP) not only removes diseased gum tissue in ... jaw bone for dental implants. , LANAP uses ... It can also help stimulate the healthy tissue as well ...
(Date:5/19/2013)... Yeast infections are common in both men and women. ... human body. A new yeast infection treatment product has been ... method of application to help eliminate over growth of the ... men and women searching for a natural process of yeast ... food and is stored in the intestines. In small consumable ...
(Date:5/19/2013)... Malibu, CA (PRWEB) May 19, 2013 ... model addiction treatment center, has announced this week the ... completely through the brands’ social media channels. “We ... the addiction treatment community and to get feedback regarding ... Pax Prentiss, CEO and co-founder of the Passages ...
(Date:5/19/2013)... 2013 The AMTC team will be screening ... Georgia Convention & Trade Center on June 1st. Professionals and ... auditions are free of charge. , Actors, Models and Talent ... of successful artists and grads like Caitlin Kinney - SYTYCD, ... , Chris Young - on his Liquid Neon 2013 Tour, ...
Breaking Medicine News(10 mins):Health News:Pradaxa Lawyers at Bernstein Liebhard LLP Report on Recent Status Conference in Federal Pradaxa Litigation 2Health News:Pradaxa Lawyers at Bernstein Liebhard LLP Report on Recent Status Conference in Federal Pradaxa Litigation 3Health News:Berkeley, CA Periodontist, Dr. Keith Chertok Now Treats Gum Disease Patients With Laser Gum Surgery Prior to Placing Dental Implants 2Health News:A Safe & Homeopathic Yeast Infection Relief by Yeastrol Now Available at HealthCareSupplementz.com with Massive Discount 2Health News:Passages Malibu Announces its Sobriety, Health, and Wellness Social Media Survey 2Health News:Passages Malibu Announces its Sobriety, Health, and Wellness Social Media Survey 3Health News:Actors, Models and Talent for Christ Hosting Auditions in Columbus, GA June 1st in Search of Local Talent 2
... latest NHS news it is said that the breast cancer drug ... patients. But this is not happy news to the grieving family ... breast cancer. But NHS officials denied her the drug which led ... ,By profession she was an advertising art director from ...
... a plan to improve the bedside manners of would-be doctors. ... will be "embedded" with patients suffering from a chronic illness ... ,This program will be compulsory for the students and ... the US. "I think it would be ideal to have ...
... shaky from terror bombings and the 2004 tsunami, was ... parts of this Javanese cultural city, a prime tourist ... its cultural history, temples and vibrant arts and crafts ... overseas tourists. ,"We're suffering another setback," said ...
... claimed that ancient trees could provide clues to the pattern of ... Pingri, 75, from Guangdong Academy of Sciences has opined that rising ... but in fact was a part of the cyclical order of ... ancient trees, I discovered the temperature throughout history has risen and ...
... Initiated by their professor - high school and college students ... ,Isolation and characterisation of 30 macrophages has been made ... Genetics issue of June 9, 2006 has a report of ... the University of Pittsburgh. The report is about the characterization ...
... colleagues at the Indiana University Medical Center, Indianapolis say ... into having unwanted sex //. ,Unwanted sex ... researchers write in the June issue of the Archives ... result in risk for sexually transmitted infections and pregnancies. ...
Cached Medicine News:Health News:Indonesian Tourism on Downward Trend After Java Quake 2